Hoth Therapeutics Inc (NASDAQ: HOTH) Could See A Rise In Prices Shortly.

In the last trading session, 1.05 million shares of the Hoth Therapeutics Inc (NASDAQ:HOTH) were traded, and its beta was 0.81. Most recently the company’s share price was $1.08, and it changed around -$0.08 or -6.90% from the last close, which brings the market valuation of the company to $7.46M. HOTH currently trades at a discount to its 52-week high of $3.80, offering almost -251.85% off that amount. The share price’s 52-week low was $0.58, which indicates that the current value has risen by an impressive 46.3% since then. We note from Hoth Therapeutics Inc’s average daily trading volume that its 10-day average is 0.46 million shares, with the 3-month average coming to 9.05 million.

Hoth Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended HOTH as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.

Hoth Therapeutics Inc (NASDAQ:HOTH) trade information

Instantly HOTH has showed a red trend with a performance of -6.90% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.2600 on recent trading dayincreased the stock’s daily price by 14.29%. The company’s shares are currently up 44.37% year-to-date, but still down -10.74% over the last five days. On the other hand, Hoth Therapeutics Inc (NASDAQ:HOTH) is -43.16% down in the 30-day period. We can see from the shorts that 0.66 million shares have been sold at a short interest cover period of 0.03 day(s).

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 15.18%. Hoth Therapeutics Inc earnings are expected to increase by 40.87% in 2025, but the outlook is positive 41.52% per year for the next five years.

HOTH Dividends

Hoth Therapeutics Inc’s next quarterly earnings report is expected to be released in March.

Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 0.92% of Hoth Therapeutics Inc shares, and 5.53% of them are in the hands of institutional investors. The stock currently has a share float of 5.59%.